Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Shares Repurchased (2024)

Tandem Diabetes Care's Shares Repurchased history spans 1 years, with the latest figure at $30.0 million for Q1 2024.

  • For Q1 2024, Shares Repurchased changed N/A year-over-year to $30.0 million; the TTM value through Dec 2024 reached $30.0 million, changed N/A, while the annual FY2024 figure was $30.0 million, N/A changed from the prior year.
  • Shares Repurchased reached $30.0 million in Q1 2024 per TNDM's latest filing.
  • In the past five years, Shares Repurchased ranged from a high of $30.0 million in Q1 2024 to a low of $30.0 million in Q1 2024.